HMS
ALXN

Hanseatic Management Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Hanseatic Management Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,350
Closed -$1.15M – 399
2014
Q2 		$1.15M Buy
7,350
+6,191
+534% +$978K 0.74% 78
2014
Q1 		$7.62K Buy
+1,159
New +$184K 0.23% 90

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hanseatic Management Services's ALXN Position: Q3 2014 in Review

Hanseatic Management Services sold out of Alexion Pharmaceuticals (ALXN) in Q3 2014, closing a stake of 7,350 shares — an estimated $1.15M sold.

Hanseatic Management Services first reported a position in ALXN in Q1 2014 and held it in 2 quarters. The position peaked at $1.15M in Q2 2014. 522 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

  • Hanseatic Management Services reported no remaining Alexion Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Hanseatic Management Services sold 7,350 Alexion Pharmaceuticals shares in Q3 2014, an estimated $1.15M.
  • Hanseatic Management Services first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Hanseatic Management Services's Alexion Pharmaceuticals position peaked at $1.15M in Q2 2014.
  • 522 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on Hanseatic Management Services's 13F filing for Q3 2014, filed 30 Oct 2014.